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Neuronal differentiation 
induces SNORD115 expression 
and is accompanied by post-
transcriptional changes of 
serotonin receptor 2c mRNA
Tomaž Bratkovič1, Miha Modic2, Germán Camargo Ortega2,6, Micha Drukker2 & Boris Rogelj  3,4,5
The serotonin neurotransmitter system is widespread in the brain and implicated in modulation of 
neuronal responses to other neurotransmitters. Among 14 serotonin receptor subtypes, 5-HT2cR plays 
a pivotal role in controlling neuronal network excitability. Serotonergic activity conveyed through 
receptor 5-HT2cR is regulated post-transcriptionally via two mechanisms, alternative splicing and A-to-I 
RNA editing. Brain-specific small nucleolar RNA SNORD115 harbours a phylogenetically conserved 
18-nucleotide antisense element with perfect complementarity to the region of 5ht2c primary transcript 
that undergoes post-transcriptional changes. Previous 5ht2c minigene studies have implicated 
SNORD115 in fine-tuning of both post-transcriptional events. We monitored post-transcriptional 
changes of endogenous 5ht2c transcripts during neuronal differentiation. Both SNORD115 and 
5ht2c were upregulated upon neuronal commitment. We detected increased 5ht2c alternative exon 
Vb inclusion already at the stage of neuronal progenitors, and more extensive A-to-I editing of non-
targeted sites A and B compared to adjacent adenosines at sites E, C and D throughout differentiation. 
As the extent of editing is known to positively correlate with exon Vb usage while it reduces receptor 
functionality, our data support the model where SNORD115 directly promotes alternative exon 
inclusion without the requirement for conversion of key adenosines to inosines, thereby favouring 
production of full-length receptor isoforms with higher potency.
Serotonin receptor 2 C (5-HT2cR) is a member of the 7-transmembrane-spanning receptors that convey sig-
nals through coupling with intracellular guanine nucleotide-binding proteins (G proteins). It is expressed almost 
exclusively in the central nervous system, where its activity is associated with control over neuronal network 
excitability. 5-HT2cR was implicated in regulation of a variety of physiological functions such as mood, satiety 
and reproduction, and aberrant 5-HT2cR signalling might underlie anxiety, depression, schizophrenia, and obe-
sity1. Regulation of 5-HT2cR signalling is highly complex and it is recognized that receptor activity is controlled 
at several regulatory layers2. Adenosine deaminases acting on RNA (ADARs) convert specific adenosines in the 
5ht2c primary transcript to inosines (the phenomenon is known as A-to-I editing). As inosine is recognized by 
translational machinery as guanine, this diversifies the genetic code post-transcriptionally, resulting in amino 
acid substitutions with regard to the genetically encoded receptor3. There are five closely spaced adenosines 
(denoted A-E) with editing potential contained within the alternative exon Vb (Fig. 1). ADAR enzymes act on 
the double-stranded RNA structure resulting from intron V folding back on exon Vb; ADAR1 preferentially edits 
positions A and B, whereas position D is selectively edited by ADAR2; positions E and C are deaminated by both 
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enzymes4. Exon Vb encodes the second intracellular loop through which the receptor couples to G proteins3. 
Functional characterization of 5-HT2cR isoforms produced as a consequence of A-to-I editing revealed dimin-
ished receptor constitutive activity5–8, potency3,8,9, and agonist affinity10 as compared to the unedited receptor. 
Furthermore, editing seems to be regulated in a serotonin-dependent manner as mice treated with a serotonin 
re-uptake inhibitor display perturbed A-to-I editing resulting in expression of receptor isoforms with higher 
serotonin sensitivity11. Finally, 5ht2c primary transcript is subjected to alternative splicing12, whereby skipping of 
the alternative exon Vb leads to translational shift resulting in an early stop codon, terminating translation after 
the third transmembrane domain (Fig. 1). Both mRNA isoforms were detected in various regions of mouse and 
human brain at different ratios8,12 and thus appear to be stable. An in vitro study on cells transfected with cDNA of 
both splice receptor isoforms revealed that the truncated receptor localizes in the endoplasmic reticulum where 
it sequesters the full-length isoform, preventing it to reach plasma membrane13. Recently, Zhang et al. confirmed 
the existence of truncated receptor isoform in mouse brain14. It has been shown that editing has a deciding role 
in splice site selection13,15.
Alternative exon Vb contains a phylogenetically conserved 18-nucleotide sequence with perfect complemen-
tarity to the brain-specific C/D-box small nucleolar RNA (snoRNA) SNORD11516 (Fig. 1), suggesting its involve-
ment in the fine tuning of serotonergic signal transduction. snoRNAs are a group of short non-coding RNAs 
principally involved in post-transcriptional modification of ribosomal and small nuclear RNAs17. As a part of rib-
onucleoprotein complexes, C/D-box snoRNAs specify individual nucleotides of substrate RNAs for 2′-O-ribose 
methylation by partner enzyme fibrillarin through Watson-Crick base pairing. In humans, SNORD115 genes 
constitute an intronic cluster within the paternally-imprinted locus 15q11-q13 (syntenic region in mice is found 
on chromosome 7) that harbours, in addition to protein-coding genes, several other conserved orphan snoRNAs, 
including SNORD116. Orphan snoRNAs lack any obvious base-pairing with the canonical target RNAs, and 
their biological role remains elusive. Deletions in the 15q11-q13 locus18–21 were identified as the genetic cause 
of Prader-Willi syndrome (PWS), a rare neurological disorder, characterized by developmental, behavioural, 
and psychiatric problems. Subjects with PWS present some features which can be explained by dysregulation of 
serotonergic system, such as obsessive-compulsive behaviour, and selective serotonin re-uptake inhibitors are 
sometimes prescribed to ameliorate the symptoms22,23. Although recently a microdeletion encompassing the 
entire SNORD116 gene cluster was determined as the minimal requirement underlying PWS phenotype21, lack of 
SNORD115 expression likely contributes to the disorder.
The most compelling evidence implicating SNORD115 in modification of 5ht2c pre-mRNA comes from stud-
ies on cell models. However, whereas Vitali et al.4 showed that SNORD115-guided ribose methylation inhibits 
A-to-I editing selectively at position C, Kishore and Stamm24 demonstrated that SNORD115 affects alterna-
tive splicing in a methylation-independent manner, plausibly by transiently associating with a silencer element 
at the proximal splice site to promote exon Vb inclusion. These studies were performed on neuroblasts and/
or fibroblasts transiently transfected with engineered 5ht2c minigenes that were either artificially targeted to 
nucleolus4, the site of SNORD115 accumulation, or had their distal splice site (Fig. 1) mutated to mammalian 
consensus to activate splicing in immortalized cell line24. The difference in technical setup might explain con-
trasting conclusions on the biological role of SNORD115. It would thus be highly informative to examine the 
post-transcriptional changes of the wild-type 5ht2c gene expressed from the native promoter.
Figure 1. Depiction of alternative splicing and A-to-I editing positions (denoted A to E) within the 5ht2c 
transcript. Stop signs symbolize stop codons. GU dinucleotide of the alternative 5′ donor splice site is 
underlined. RNA duplex is formed between an 18-nucleotide 5ht2c segment and SNORD115 antisense region. 
Characteristic nucleotide motif in SNORD115 (the D-box) is boxed and adenosine on 5ht2c transcript located 
5 nucleotides upstream, which is presumed to be targeted for 2′-O-methylation (coinciding with the editing 
position C), is denoted by an asterisk. Pss, proximal splice site; Dss, distal splice site.
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However, ectopic expression of full length 5ht2c is difficult due to gene spanning over 326 kb. On the other 
hand, functional studies of snoRNAs are hampered by the fact that they are highly structured and shielded by part-
ner proteins within the nucleolar ribonucleoprotein complexes, rendering gene knock-down approaches difficult to 
implement25,26. Thus, reports of successful snoRNA knock-down experiments are scarce25,27,28. More importantly, 
SNORD115 knock-down is complicated by redundancy as there are numerous homologous copies of the gene.
By analysing recent RNA-seq data on whole transcriptome profiling of murine embryonic carcinoma cell 
line P1929, we observed that both SNORD115 gene cluster and 5ht2c are strongly upregulated following retinoic 
acid-induced neuronal differentiation. To get insight into dynamic post-transcriptional processes affecting 5ht2c 
transcript during neuroectodermal differentiation in conjunction with increased expression of SNORD115, we 
monitored its splicing and A-to-I editing profiles throughout transition of pluripotent P19 cells to neurons.
Results
Choice of cell line and induction of neuronal differentiation. RNA-seq analysis (Fig. 2) built on avail-
able dataset29 showed that neurons produced from P19 cell line express SNORD115 and 5ht2c genes at levels up to 
2 orders of magnitude higher than the neuronal precursors with neuronal 5ht2c transcripts being 200-fold under-
represented compared to combined SNORD115 cluster members (it should be noted, however, that the seemingly 
low 5ht2c expression might in fact be due to extensive A-to-I editing which prevents the correct annotation of 
edited reads). Differentiating P19 cells were thus chosen as a model system to monitor 5ht2c post-transcriptional 
modifications in correlation with SNORD115 expression changes.
Neuronal differentiation of pluripotent cell line P19 was triggered by treating floating cell aggregates with RA 
and finally plating trypsinized cells on poly-D-lysine plates. Cells at progressing stages of differentiation were 
stained with antibodies against a set of markers, confirming differentiation status (Fig. 3). Neural progenitors 
(Pax6 + /Nestin + ) were enriched on the second day of neuronal induction (i.e. upon plating on adhesive tissue 
culture dishes), and neurons (Tubb3 + ) appeared from day 4 of differentiation onwards. Throughout differen-
tiation a homogenous population of cells was observed, in line with a previous report on neuronal induction of 
murine embryonic stem cells using an analogous protocol30, and no selective trypsinization was needed to enrich 
for neuronal cells.
qPCR analyses of gene expression changes during neuronal differentiation. In mice, 
SNORD115 and SNORD116 are encoded in large intronic clusters of multiple highly homologous copies. We 
semi-quantitatively analysed SNORD115/116 expression in murine pluripotent stem cell (mPSC)-derived neu-
rons and retinoic acid (RA)-induced P19-neurons by qPCR. Whereas SNORD115 and SNORD116 were not 
detected in mPSC-derived neurons, they were strongly induced by RA and their expression levels rose with neu-
ronal differentiation stage (Fig. 4a). In comparison, the level of SNORD45B, a canonical snoRNA predicted to 
guide the 2′-O-ribose methylation at U172 of 18 S rRNA31, was unaffected by RA treatment (Fig. 4a). We next 
looked at the expression of 5ht2c and found similar profiles to PWS locus snoRNAs; 5ht2c mRNA was absent in 
mPSC-derived neurons, very poorly expressed in P19 cell line, but induced by RA (Fig. 4b). Primers for 5ht2c 
long splice variant quantification were positioned so as to amplify the cDNA isoform regardless of editing. Both 
splice variants were readily detected and had qualitatively similar expression profiles. Finally, we determined 
expression of SNORA35 (Fig. 4b), a brain-specific snoRNA harboured in the second intron of 5ht2c gene. Some 
pre-mRNAs have been shown to transiently localize to the nucleolus32. The presence of intronic snoRNA in the 
5ht2c gene could suggest that the primary transcript is trafficked through the nucleolus where it may encounter 
SNORD115. Qualitatively, SNORA35 displayed similar profiles to those of 5ht2c and PWS snoRNAs but was 
expressed at significantly lower degree in all cells analysed (see also Fig. 2). The qPCR data are in agreement with 
gene expression profiles previously determined with RNA-seq29.
The proportion of 5ht2c long splice isoform increases upon neuronal commitment. Only the 
long 5ht2c splice isoform is translated to receptor capable of signal transmission, whereas the short splice isoform 
gives rise to truncated receptor sequestering the full length receptor intracellularly13,14. To examine whether 5ht2c 
splicing changes are coupled with neuronal differentiation, we assessed the alternative exon Vb usage in P19 cells 
during the time course of neuronal differentiation. At pluripotency stage the P19 cells transcribe extremely low 
levels of 5ht2c (Fig. 4b), making quantification of splicing challenging. Only upon induction of differentiation, 
when 5ht2c expression is significantly increased, can quantitative splicing changes be determined. As deduced 
from qPCR data, the ratio of long to short isoform remained constant from neural progenitors to neurons 
Figure 2. Heat map of expression levels (log-transformed transcript per kilobase million (TPM) values) 
for selected genes during the course of retinoic acid-induced neural differentiation of P19 cells. Figure was 
generated based on RNA-seq data from Rybak-Wolf et al.29. NPC, neural progenitor cell; ND, not detected.
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(92.2 ± 0.8, 91.1 ± 0.5, 90.5 ± 0.6 percent, respectively, in favour of the long isoform; Fig. 5a). We re-analysed the 
splicing profile by a complementary technique, RT-PCR and densitometric quantification of amplicons (Fig. 5b). 
Here, the ratio of amplicons of cognate isoforms should reflect their initial proportion irrespective of the input 
amount. Nevertheless, we used 35-fold more cDNA per PCR reaction to ensure that the rare transcripts were not 
overlooked. With this approach we confirmed that the proportion of long splice isoform was highly comparable 
among later time points (i.e., 86.2 ± 1.6, 87.3 ± 0.5, 86.7 ± 0.4 percent, respectively). In contrast, we observed a 
significantly smaller proportion of long splice isoform in pluripotent P19 cells (50.9 ± 5.9 percent; p < 0.0001, 
one-way ANOVA with Bonferroni post hoc test). These data indicate that the splicing profile of 5ht2c shifts 
towards full length isoform once the cells commit to neuronal differentiation.
The extent of 5ht2c A-to-I editing is low at sites overlapping with SNORD115 binding region. 
Having observed changes in alternative splicing of 5ht2c transcript, we next quantified A-to-I editing levels at 
each of the 5 editing sites during RA-induced neuronal differentiation (Fig. 6 and Supplementary Figure S1). 
Although direct amplicon sequencing does not support analysis of individual mRNA variants, it is convenient for 
assessing the overall editing levels at individual nucleotide positions33. During preliminary qPCR gene expression 
profiling we determined that in neurons, expression levels of adenosine deaminases ADAR1 and ADAR2 are 
approximately 2- and 3-fold higher, respectively, compared to the pluripotency stage (Supplementary Figure 2); 
we stress, however, that the primers for quantification of ADAR transcripts were designed so as not to discrim-
inate among numerous ADAR splice isoforms and thus gene expression levels do not necessarily correlate with 
enzymatic activity.
Figure 3. In vitro differentiation of P19 cells mimics early processes in mammalian neuroectodermal 
development in vivo. (a) and (b) Confocal images of P19 cells stained with anti-Oct4 and anti-NANOG 
antibody (FITC-green), respectively. (c) Confocal images of P19-derived neural progenitor cells (NPCs) on the 
second day of neuronal induction upon plating on adhesive tissue culture dishes stained with anti-Pax6 (FITC-
green) and anti-nestin (FITC-Texas). (d) Neuronal precursors become post-mitotic and undergo end-terminal 
differentiation, observed by confocal microscopy of neurons stained with anti-Tubb3 on day 6 of neuronal 
differentiation upon plating on adhesive tissue culture dishes. Cell nuclei were counterstained with DAPI. 
Images of immuno-staining and DAPI staining were overlaid. Scale bar represents 10 micrometers.
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We noted that at positions A and B, the only two sites not overlapping with the SNORD115 antisense element 
(Fig. 1), editing levels were highest already in P19 cells and further increased throughout neuronal differentiation 
to reach 78 ± 10% and 58 ± 4%, respectively. At position D editing was less pronounced, amounting to 31 ± 4%, 
whereas adenosines at sites E and C were deaminated only to a minor extent (i.e., 3 ± 2% and 10 ± 5%, respec-
tively, in neurons). The differentiation-related increase in editing levels was observed for all positions with the 
exception of D (Fig. 6).
We estimated the accuracy of A-to-I editing determination. Plasmid-harboured single 5ht2c fragment clones 
differing in editing at 3 positions were mixed in different ratios and sequenced. Guanosine peak hights relative to 
the sum of adenosine and guanosine peak heights were plotted against the defined G to A ratio (Supplementary 
Figure 3). For G to A ratios in the range of 20:80 to 80:20, the curve is linear. In this range, G content is overesti-
mated by roughly 10 percentage points. At lower and higher G to A ratios, the shape of the calibration curve turns 
sigmoidal, allowing somewhat less accurate determination of editing extent; an observation, that is consistent 
with findings of Wahlstedt et al.34. Thus, editing, as analysed here, is likely slightly overestimated at positions A 
and B, and underestimated at sites E and C. Nevertheless, less extensive editing is evident for positions E, C and 
D relative to that at sites A and B.
Figure 4. snoRNAs and 5ht2c mRNAs levels are gradually upregulated during neuronal commitment. (a) RA-
induced neuronal differentiation unlocks expression of PWS locus snoRNAs SNORD115 and SNORD116, but 
does not affect expression of canonical snoRNA SNORD45B. (b) Neuronal differentiation induces expression 
of both serotonin receptor 2c splice variants as well as SNORA35, snoRNA harboured in the second intron of 
5ht2c gene. Primer design is depicted for 5ht2c splice variants. Averaged data of three biological repeats per time 
point ± standard deviation are shown. mPSC-dn, murine pluripotent stem cell-derived neurons; X days, time 
after induction of neuronal differentiation.
Figure 5. Analysis of splicing for the 5ht2c transcript in P19 cells and during RA-induced neuronal 
differentiation. (a) Percentage of long splice isoforms as inferred from the qPCR expression data. See Fig. 4b 
for depiction of primer pairs used to detect the two isoforms. White column denotes low reliability of data 
due to extremely low 5ht2c expression. (b) Percentage of long splice isoforms as deduced by densitometric 
quantification of RT-PCR amplicons corresponding to the long and short splice isoforms. Averaged data of three 
biological repeats per time point ± standard deviation are shown.
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Discussion
The studies by Vitali et al.4 and Kishore and Stamm24 addressed the potential role of SNORD115 in regulation 
of post-transcriptional events of the 5ht2c transcript in cells cotransfected with engineered 5ht2c minigenes and 
SNORD115. Of note, in these experiments the minigenes were either artificially targeted to nucleolus (where 
SNORD115 accumulates) by means of RNA polymerase I promoter, or the experimenters relied on mutated distal 
splice site to achieve efficient splicing of minigenes in immortalized cell line. As manipulating 5ht2c gene might 
have skewed the interpretation of observed effect (indeed, the studies attributed distinct roles to SNORD115 with 
regards to post-transcriptional processing of 5ht2c), we monitored alternative splicing and A-to-I editing profiles 
of endogenously expressed serotonin receptor 2c transcript throughout retinoic acid-induced neuronal differen-
tiation of murine embryonic carcinoma cell line P19 that concomitantly expresses SNORD115.
Over the course of neuronal differentiation the expression of both SNORD115 and 5ht2c was strongly induced. 
We observed an increase in 5ht2c alternative exon Vb usage upon neuronal commitment (Fig. 5). The levels of 
ADAR genes’ expression rose steadily with differentiation stage (Supplementary Figure 2), which is consistent 
with markedly increasing adenosine deamination at most editing sites (Fig. 6). Notably, positions that overlap 
with SNORD115 antisense element (i.e., C through E) were poorly edited. Tohda et al.33 who analysed editing of 
5ht2c mRNA in rat brain cortex during pre- and postnatal development, made observations similar to ours and 
speculated that factors other than ADAR enzymes must affect differential susceptibility of individual adenosines 
to deamination. One explanation for the observed phenomenon is that SNORD115-containing snoRNPs mask 
the distal editing sites, thereby competing with ADAR activity.
Site C adenosine is the nucleotide that was predicted to be targeted for 2′-O-ribose methylation by 
SNORD115-associated methyltransferase fibrillarin16 (Fig. 1). In in vitro experiments on synthetic substrates35 it 
has been demonstrated that deamination of adenosines with 2′-O-methylated ribose is greatly reduced. This does 
not, however, account for the low extent of editing observed at positions E and D. Instead, our data favour a model 
proposed by Kishore and Stamm24 in which SNORD115 directly promotes formation of 5ht2c long splice isoform 
by masking the silencer of splicing element overlaping with the distal editing sites. In line with that, SNORD115 
has been found to associate with non-canonical partner proteins36,37, further questioning its role in 2′-O-ribose 
methylation.
Flomen et al.15 performed a detailed analysis of the effect of adenosine deamination on splice site selection of 
5ht2c. By transfecting 5ht2c minigenes spanning from exon Va to exon VI with combinations of adenosines at 
editing sites substituted for guanosines (simulating inosines) and quantifying exon Vb usage, they have shown 
that editing at positions A and B alone is insufficient to promote exon Vb retention. However, when editing 
at sites E, C, and/or D was simulated in addition to mutation of the proximal sites, the splicing equilibrium 
shifted markedly towards the long isoform. The shift can likely be attributed to alteration of the binding sites for 
trans-acting splice factors. As editing at positions C and E most strongly negatively influences 5-HT2cR receptor 
signalling3,7,8, SNORD115 seems to favour the generation of highly functional receptor isoforms by promoting 
exon Vb retention without the need for extensive editing38. Indeed, increased 5ht2c mRNA editing was observed 
in post-mortem hippocampal regions of individuals suffering from PWS (lacking SNORD115 expression) but 
the splicing profile was indistinguishable from that of healthy controls24. On the other hand, a study performed 
on frontal cortices39 did not reveal consistent differences in the extent of 5ht2c mRNA editing in PWS patients 
with confirmed SNORD115 deletion as compared to healthy controls. This discrepancy might be explained by 
the fact that editing was studied in different brain regions. Indeed, A-to-I editing is known to vary considerably 
across brain anatomy8.
Figure 6. Determination of A-to-I editing levels by direct PCR sequencing. Averaged data ± standard deviation 
are shown. Statistically significant changes in the extent of editing (relative to undifferentiated P19 cells) are 
denoted by asterisks (Kruskal-Wallis one-way analysis of variance with Dunn’s post hoc test; *Padjusted < 0.1; 
**Padjusted < 0.05; ***Padjusted < 0.01).
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Studies on transgenic animals corroborate the complex interplay between 5ht2c splicing and A-to-I edit-
ing and support the role of SNORD115 in fine-tuning of both post-transcriptional events. In mice expressing 
solely the fully edited receptor isoform, the 5ht2c short splice isoform was produced to a significantly lesser 
extent13, leading to diminished sequestration of the full length receptor in endoplasmic reticulum. These mice 
thus expressed more 5-HT2cR than the wild type animals, and even though the fully edited isoform has com-
promised signalling activity, displayed anxiety-like behaviour when treated with a preferential 5-HT2cR agonist. 
Interestingly, an earlier study40 on mice mutants expressing the fully edited receptor isoform found no differences 
in the 5ht2c splicing profile compared to the wild-type mice. It did, however, confirm increased 5-HT2cR den-
sity in all analysed brain areas as judged by radioactively labelled receptor agonist binding. This observation is 
even more meaningful if one considers lower ligand affinity towards edited isoforms10. In transgenic mice with 
inactivated PWS locus (lacking SNORD115 expression) initially only increased editing but no changes in splicing 
profile of 5ht2c pre-mRNA were found41, but a later more neuroanatomically refined analysis revealed a higher 
proportion of short splice isoform in the hypothalamus42.
Cell lines endogenously expressing 5ht2c and SNORD115 have not been described. As RA-induced neuronal 
differentiation of P19 cells seems to faithfully recapitulate the processes that 5ht2c transcript is subjected to in 
conjunction with SNORD115 upregulation, and since neuronal induction is fast and efficient, P19 cell line repre-
sents an interesting model system for studying PWS snoRNA functions. Given the role of 5-HT2cR in regulation 
of neuronal network excitability1, one can imagine that fine-tuning its activity should be of crucial importance for 
the developing neural system. In this respect, SNORD115 as a factor that both replaces and selectively counteracts 
ADAR activity at 5ht2c transcript would be essential for normal neurogenesis.
Although not being sufficient for the onset of the disorder, SNORD115 cluster deletion is likely to augment 
the phenotypic characteristics of PWS through loss of the post-transcriptional fine-tuning mechanism of 5ht2c 
transcript. Three studies strongly support this hypothesis. Mice lacking expression of PWS locus genes exhibited 
alterations in specific 5-HT2cR-related behaviours along with increased RNA-editing of the 5ht2c pre-mRNA41. 
The same genetic mouse model of PWS was later shown to be unresponsive to anorexic doses of preferential 
5-HT2cR agonist which was attributed to increased proportion of 5ht2c short splice isoform in hypothalamic 
pro-opiomelanocortin neurons42. Furthermore, transgenic mice expressing solely fully edited 5-HT2cR isoform 
presented certain phenotypic traits of PWS, including failure to thrive, neonatal muscular hypotonia and reduced 
food consumption with subsequent (post-weaning) hyperphagia43. Etiology of PWS is complex and cannot be 
explained solely by the lack of SNORD115 expression, especially in light of recent evidence of SNORD116 dele-
tion being responsible for sleep disorders44, growth retardation45, and body weight regulation46,47 in mice PWS 
models and/or PWS patients. Yet, there is mounting evidence to suggest an adjunctive role of SNORD115 in 
this genetic disorder. The exact role of PWS locus orphan snoRNAs remains to be determined. New and unex-
pected roles have been ascribed to several canonical and orphan snoRNAs in recent years (27,48–52 and reviewed 
in53), straitening our convictions that this class of non-coding RNAs is more than a simple regulator of rRNA 
decoration.
Materials and Methods
Global profiling of gene expression. Annotated RNA-seq data of P19 cell line undergoing neuronal dif-
ferentiation (GEO accession numbers: GSM1665895, GSM1665896, GSM166589729) with calculated TPM values 
were acquired from Rajewsky lab (Max Delbrück Center for Molecular Medicine, Berlin, Germany). A heat map 
(Fig. 2) was generated in Excel for SNORD115 and SNORD116 clusters, 5ht2c, SNORA35, ADAR1, ADAR2, and 
sets of pluripotency, neural progenitor cell, and neuronal lineage markers for graphic presentation of expression 
changes during differentiation.
Retinoic acid-induced neuronal differentiation of P19 cells. All experiments were performed on 3 
biological replicates.
Pluripotent P19 cells (ATCC CRL1825) were cultured in growth medium (alphaMEM (Life Technologies), 
10% fetal calf serum, 100 U/mL Penicillin and 100 µg/mL Streptomycin) at 37 °C and 5% CO2 and passaged 
every third day. Neural differentiation was induced by growing 3 × 106 cells for four days on neural induction 
medium (alphaMEM, 5% FCS, 100 U/ml penicillin, 100 µg/mL streptomycin, 5 µM all-trans retinoic acid (RA)) 
on 100 mm nonadhesive bacterial petri dishes to promote cell aggregation. Afterwards, cell aggregates were col-
lected, mechanically and enzymatically (0.05% trypsin) dissociated and plated on poly-D-lysine coated plates 
or coverslips and grown in neuronal induction medium (DMEM/F12 Glutamax (Life Technologies), 2% B27, 
8 mM HEPES, 100 U/mL penicillin, 100 µg/mL streptomycin, 5 µM RA) for 6 days. We added 10 µM cytosine 
β-D-arabinofuranoside to the medium on the second day of neuronal differentiation in order to inhibit growth of 
dividing progenitors which would otherwise generate glia-like cells.
Neural conversion of murine pluripotent stem cells. mPSC were differentiated from culture grown 
in monolayer without the step involving the formation of embryoid bodies or treatment by RA. First, mPSC 
were trypsinized, resuspended, quantified in a Neubauer counting chamber and transferred to uncoated 6-well 
cell culture plates. Following a 50-min-incubation period, supernatants were transferred to wells coated with 
poly-ornithine and laminin, maintaining cell densities at 2 × 104 cells/cm2. Prior to initial dissociation step, 12 
ng/mL bFGF was added to ESC culture medium (83% KnockOut DMEM, 15% KnockOut Serum Replacement 
(KSR), 0.1 mM non-essential amino acids, 1% Glutamax; Life Technologies) and incubated for 6 h in absence 
of LIF. Next, cells were dissociated and incubated in ROCK-Inhibitor (Y-27632; StemCell Technologies) in 
10% KSR-medium (79% KnockOut DMEM, 20% KSR, 0.1 mM non-essential amino acids, 2 mM glutamine, 
1 × 2-mercaptoethanol (Millipore)), supplemented with LDN193189 (LDN; 100 nM) and SB431542 (SB; 10 µM). 
At day 1 of differentiation, medium was changed to 5% KSR and 0.5% N2-supplement with PD0325901 (PD; 
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1 µM) on top of before listed inhibitors. Neural conversion was induced using the following protocol. On day 
4, medium was changed to N2 based medium (DMEM/F-12 Glutamax, 1 × N2-supplement, 200 µM ascorbic 
acid) supplemented with 100 ng/ml FGF8, 100 ng/ml WNT1, 100 nM LDN and 10 µM SB. At day 6, medium was 
replaced with N2/B27 medium (50% DMEM/F-12 Glutamax, 50% Neurobasal Medium, 0.5 × N2-supplement, 
0.5 × B27-supplement, 200 µM ascorbic acid) supplemented with 100 ng/ml FGF8, 100 ng/ml WNT1 and 100 nM 
LDN. FGF8 was omitted on day 8 from neuronal induction culture, and from this day onwards cells were differ-
entiated in B27 medium (Neurobasal Medium, 1 × B27-supplement, 2 mM glutamine, 200 µM ascorbic acid) with 
medium being changed every two days using the following supplements (from day 8 to day 9: 100 ng/ml WNT1 
and 100 nM LDN; from day 10 to day 11: 100 ng/ml WNT1). From day 11 of differentiation onwards, only BDNF 
(20 ng/ml) was added to B27 medium and differentiation was stopped at day 20.
Immunocytochemistry. Cell markers were stained with antibodies given in Table 1. Imaging was per-
formed with an Olympus FV1000 cLSM/MPE system, composed of a BX- 61WI upright microscope (Olympus), a 
laser diode 559 nm, a multi-line Argon laser (458 nm, 488 nm, Showa Optronics Co.) and internal photomultiplier 
tube detectors. Image analysis was performed using the FW10-ASW 4.0 software (Olympus).
qPCR analysis of gene expression. RNA was isolated from P19 cells at different time points of neuronal 
differentiation (0, 2, 4, and 6 days after plating cells on poly-D-lysine-coated plates) using the miRNeasy kit 
(Qiagen, Venlo, Netherlands). For mPSC-derived neurons, RNA was isolated from fully differentiated culture 
only. 1 µg of total RNA was reverse transcribed with random primers in 10 µL reactions using the SuperScript 
VILO cDNA Synthesis Kit (Thermo Fisher Scientific, Waltham, MA, USA) following the manufacturer recom-
mendations. Gene expression was profiled with qPCR using Maxima SYBR Green qPCR Master Mix (Thermo 
Fisher Scientific) on LightCycler 480 (Roche, Basel, Switzerland). Primers (Table 2) were either acquired from 
literature or designed for the purpose of this study based on gene sequences accessed from Ensembl Genomic 
Browser. 0.63 ng cDNA was used per 10 µL reaction. Expression levels were normalized to Actb and HPRT 
mRNA, which were indicated as most stably expressed among 5 tested potential reference genes (Actb, HPRT, 
Antigen Host/IgG Dilution Clone Company Cat. No.
Oct3/4 mouse IgG2b 1:500 C-10 SantaCruz sc-5279
Nanog rabbit 1:500 polyclonal CellSignaling D73G4
Pax6 rabbit 1:500 polyclonal Millipore AB2237
Nestin mouse IgG1 1:500 rat-401 Millipore MAB353
Tubb3 mouse IgG2b 1:2000 SDL.3D10 SigmaAldrich T8660
Table 1. Antibodies used for immunocytochemistry.
Gene Primer pairs Sequences (5′ → 3′)
Tann 
[°C]
PrimerBank 
ID
Actb
F-Actb GGCTGTATTCCCCTCCATCG
54 6671509a1
R-Actb CCAGTTGGTAACAATGCCATGT
HPRT
F-HPRT TCAGTCAACGGGGGACATAAA
54 7305155a1
R-HPRT GGGGCTGTACTGCTTAACCAG
SNORD115
F-115 TCAATGATGACAACCCAATGTC
50 /
R-115 CTCAGCGTAATCCTATTGAGCAT
SNORD116
F-116 ATCTATGATGATTCCCAGTCAAACATTC
50 /
R-116 GATGAGAGTGGCGGTACAG
SNORA35
F-35 CAAGTGACCCATTGGACTTTTTCTTG
52 /
R-35 TGTGACTCTCCCATCTTTCGG
SNORD45B
F-45B ATGGCATGTATTAGCTGAATGCTAACC
50 /
R-45B AAGGTCTCAGTGTAATTTGTAACTTGC
5ht2c
(long isoform)
F-5HT2c_long GCCATCATGAAGATTGCCATCGTTTG
55 /
R-5HT2c_long CACGCAGGTAGTATTATTCACGAACACT
5ht2c
(short isoform)
F-5HT2c_short ATCGCTGGACCGGAGTTTC
55 /
R-5HT2c_short GTTCGGGTCATTGAGCACGC
ADAR1
F-Adar1 CAGAGGCACTGTGGATGGAC
54 /
R-Adar1 CATAGTCACGGGCAGCTTTCTTG
ADAR2
F-Adar2 GTGACAAGATAGCACGCTGGAAC
54 /
R-Adar2 TATGTTGGAGATCCGCTGGTACATG
Table 2. Primer pairs used for qPCR analysis of gene expression. All primers were used at 300 nM, except for 
5HT2c_long/short pairs, which were used at 200 nM.
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SNORD45B, RPL27 and Tubb3) by NormFinder54. Reactions were analysed by agarose gel electrophoresis to 
confirm the presence of a single amplicon and reaction specificities were backed up by melting curve analysis. 
No reverse transcription controls indicated negligible extent of genomic DNA contamination of RNA isolates 
(Supplementary Figure 4).
Analysis of alternative splicing for 5ht2c transcripts. Potential changes in 5ht2c alternative exon Vb 
usage during P19 neuronal differentiation were analysed by qPCR with primers given in Table 2. Additionally, 
ratio of long to short receptor isoform was assessed by touchdown end-point PCR. Here, 22 ng of cDNA was 
used per 15 µL reaction. Primers F1-m5HTR2c (5′-CTAGATATTTGTGCCCCGTCTG-3′) and R1-m5HT2cR 
(5′-GTCATTGAGCACGCAGGTAGTA-3′) were used at 200 nM concentration and PCR conditions were: 30 
cycles of 30 s at 95 °C, 2 min at 60 °C with a decrease of 0.5 °C each cycle, and 2 min at 72 °C, followed by 15 cycles 
of 30 s at 95 °C, 1 min at 45 °C and 1 min at 72 °C, and a final extension step of 7 min at 72 °C. Amplicons were sep-
arated on 2.5% agarose gel (one third of the reaction was loaded) and stained with ethidium bromide. Stain flu-
orescence intensities were quantified on G Box imager (Syngene, Cambridge, UK) and analysed with GeneTools 
software, normalizing signals to amplicon length.
Analysis of A-to-I editing. A-to-I editing levels were quantified by sequencing. The 280-nucleotide 5ht2c 
gene segments encompassing editing sites A to D were amplified using primers F2-m5HT2cR 
(5′-CAATGCTACCAATTATTTCTTAATGTC-3′) and R2-m5HT2cR (5′-AACGATGGCAATCTTCATG-3′). 
50 μL reactions were performed with 40 ng cDNA at 35 cycles of 20 s at 95 °C, 30 s at 51 °C, and 1 min at 72 °C. 
Amplicons were purified using QIAquick PCR purification Kit (Qiagen, Venlo, Netherlands) and sequenced 
using primer F2-m5HT2cR. The percentage of adenosine conversion to inosine at individual sites was calculated 
as = ×
+
I% 100G
G A
, where G is guanosine peak height and A is adenosine peak height.
A recent study indicated discrepancies in the extent of editing determined from peak height ratios (direct PCR 
sequencing) and distribution of NGS counts at high and low editing levels34. To check the validity of our data, we 
sequenced defined mixtures of two 5ht2c clones, subcloned in pGem-T Easy plasmid (Promega, Madison, WI, 
USA), differing in A-to-I editing (i.e. A to G transitions) at 3 positions.
Statistical analyses. For the qPCR expression analyses, data (relative gene expression normalized to 
geometric mean of Actb and HPRT) are presented as mean values for 3 biological repeats in each group ± stand-
ard deviation. For the quantitative splicing analyses of 5ht2c transcript, percentage of long splice isoform in each 
sample was calculated (from qPCR or densitometric measurements) and averaged across each group of 3 bio-
logical repeats. Data are expressed as average values ± standard deviation. Groups were compared with one-way 
ANOVA followed by Bonferroni post hoc test (GraphPad Prism, GraphPad Software, CA, USA). For quantitative 
A-to-I editing analyses of 5ht2c transcript, percentage of inosine at each of the five positions for each sample was 
calculated and averaged across each group of 3 biological repeats. Data are expressed as average values ± standard 
deviation. The extent of A-to-I editing at each of the five positions during neuronal differentiation was compared 
to that of undifferentiated P19 cells with Kruskal-Wallis one-way analysis of variance followed by Dunn’s post hoc 
test (GraphPad Prism).
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